Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
APL-130277
print preview
bookmark
share with colleague
General Information
Company
Cynapsus Therapeutics Inc.
Description
Sublingual thin film strip formulation of apomorphine hydrochloride, a small molecule dopamine receptor agonist
Molecular Target
Dopamine receptor
Mechanism of Action
Dopamine receptor agonist
Latest Stage of Development
Phase I
Indication
Parkinson's disease (PD)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy